|
Confirmed Speakers Include:
Jesper Wengel Professor, University of Southern Denmark
Gunter Meister Group Leader, RNA Biology, Max Planck Institute for Biochemistry, Martinsried
Mark Behlke CSO, Integrated DNA Technologies
Thomas Thum Group Leader, Julius-Maximilians-University
Silvia Monticelli Group leader, Institute for Research in Biomedicine
Georg Sczakiel Professor, Lübeck University
Sven Diederichs Group Leader, German Cancer Research Center (DKFZ) & Institute of Pathology, University of Heidelberg
Wolfgang Kemmner Group Leader, Charité Universitaetsmedizin Berlin
Hakim Djaballah Director, Memorial Sloan Kettering Cancer Center
Tobias Poehlmann Group leader, Friedrich-Schiller-University of Jena
Andras Lacko Professor, UNT Health Science Center
Jörg Vollmer Managing Director, Coley Pharmaceutical
Himanshu Brahmbhatt Joint-CEO & Director, EnGeneIC Pty Ltd
Masoud Toloue Senior Scientist, Bioo Scientific
Dmitry Samarsky Vice President of Technology Development, RXi Pharmaceuticals |